NM_001146.5:c.1337-30T>C
Variant names:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001146.5(ANGPT1):c.1337-30T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00802 in 1,589,926 control chromosomes in the GnomAD database, including 645 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.037 ( 323 hom., cov: 32)
Exomes 𝑓: 0.0049 ( 322 hom. )
Consequence
ANGPT1
NM_001146.5 intron
NM_001146.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.10
Genes affected
ANGPT1 (HGNC:484): (angiopoietin 1) This gene encodes a secreted glycoprotein that belongs to the angiopoietin family. Members of this family play important roles in vascular development and angiogenesis. All angiopoietins bind with similar affinity to an endothelial cell-specific tyrosine-protein kinase receptor. The protein encoded by this gene is a secreted glycoprotein that activates the receptor by inducing its tyrosine phosphorylation. It plays a critical role in mediating reciprocal interactions between the endothelium and surrounding matrix and mesenchyme and inhibits endothelial permeability. The protein also contributes to blood vessel maturation and stability, and may be involved in early development of the heart. Mutations in this gene are associated with hereditary angioedema. [provided by RefSeq, Aug 2020]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 8-107252045-A-G is Benign according to our data. Variant chr8-107252045-A-G is described in ClinVar as [Benign]. Clinvar id is 1247640.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.123 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANGPT1 | NM_001146.5 | c.1337-30T>C | intron_variant | Intron 8 of 8 | ENST00000517746.6 | NP_001137.2 | ||
ANGPT1 | NM_001199859.3 | c.1334-30T>C | intron_variant | Intron 8 of 8 | NP_001186788.1 | |||
ANGPT1 | NM_001314051.2 | c.737-30T>C | intron_variant | Intron 7 of 7 | NP_001300980.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0371 AC: 5641AN: 152102Hom.: 324 Cov.: 32
GnomAD3 genomes
AF:
AC:
5641
AN:
152102
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0117 AC: 2799AN: 239940Hom.: 133 AF XY: 0.00941 AC XY: 1221AN XY: 129810
GnomAD3 exomes
AF:
AC:
2799
AN:
239940
Hom.:
AF XY:
AC XY:
1221
AN XY:
129810
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00495 AC: 7110AN: 1437710Hom.: 322 Cov.: 29 AF XY: 0.00456 AC XY: 3254AN XY: 713114
GnomAD4 exome
AF:
AC:
7110
AN:
1437710
Hom.:
Cov.:
29
AF XY:
AC XY:
3254
AN XY:
713114
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0371 AC: 5648AN: 152216Hom.: 323 Cov.: 32 AF XY: 0.0350 AC XY: 2608AN XY: 74432
GnomAD4 genome
AF:
AC:
5648
AN:
152216
Hom.:
Cov.:
32
AF XY:
AC XY:
2608
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
36
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
May 10, 2021
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at